Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Zhengqiu LIAN"'
Publikováno v:
Zhongguo shuxue zazhi, Vol 36, Iss 12, Pp 1132-1135 (2023)
Objective To investigate the clinical characteristics and antibody distribution as well as evaluate the transfusion efficacy in unexpected antibody positive patients. Methods A total of 12 235 patients from January 1, 2022 to March 31, 2023 who hospi
Externí odkaz:
https://doaj.org/article/9ce28d2df56440daba26d0d88d336b55
Publikováno v:
Zhongguo shuxue zazhi, Vol 36, Iss 10, Pp 876-880 (2023)
Objective To analyze the profile of perioperative allogenic blood transfusion for single disease in patients who underwent spinal deformity correction surgery and risk factors of the blood transfusion, in order to provide reference for clinical decis
Externí odkaz:
https://doaj.org/article/ae77b2f3e8e04e0a8b09480edd43b6d0
Publikováno v:
Zhongguo shuxue zazhi, Vol 36, Iss 10, Pp 880-884 (2023)
Objective To retrospectively analyze the characteristics of blood transfusion compatibility detection in patients with delayed serologic transfusion reaction ( DSTR), in order to provide reference for safe and effective blood transfusion in clinical
Externí odkaz:
https://doaj.org/article/e4d86272cb8349f78efbc91bbbb16463
Autor:
Yunhong Yu, Zhengqiu Lian
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Transfusion-related acute lung injury (TRALI) is a severe adverse event and a leading cause of transfusion-associated death. Its poor associated prognosis is due, in large part, to the current dearth of effective therapeutic strategies. Hence, an urg
Externí odkaz:
https://doaj.org/article/cf4ce1dd0e244929b29bde10726d5234
Publikováno v:
Transfusion. 60:1434-1442
Background Transfusion-related acute lung injury (TRALI) is an important cause of death associated with transfusion, and no specific clinical treatments are available. Endothelial cells are believed to play an important role in the development of TRA